Founded in Tel Aviv, Israel, Polaris Venture Capital invests in various funding rounds, including series B, seed, venture, and series A. Its portfolio includes companies like NakedPoppy, Lyra Therapeutics, Respicardia, and BarkBox. With over $700 million under management, Polaris Venture Capital has made 16 investments and has had seven successful exits, including Cardlytics and Selecta Biosciences.